Stockreport

FDA grants accelerated review for Merck's application for Keytruda + Inlyta in first-line kidney cancer [Seeking Alpha]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF FDA grants accelerated review for Merck's application for Keytruda + Inlyta in first-line kidney cancer [Read more]